BamSEC and AlphaSense Join Forces
Learn More

Oragenics Inc. – Indentures

NYSE American: OGEN    
Share price (8/4/26): $0.55    
Market cap (8/4/26): $2.482 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.7
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.16
from S-8 1 page Third Amendment to Oragenics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-4.2
from 8-K 13 pages Oragenics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of July 2, 2025 Warrant Agency Agreement
12/34/56
EX-4.1
from 8-K 12 pages Series H Preferred Purchase Warrant Oragenics, Inc
12/34/56
EX-4.9
from S-1 13 pages Oragenics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of June __, 2025 Warrant Agency Agreement
12/34/56
EX-4.8
from S-1 13 pages Form of Series H Preferred Purchase Warrant Oragenics, Inc
12/34/56
EX-4.9
from DRS 13 pages Oragenics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of June __, 2025 Warrant Agency Agreement
12/34/56
EX-4.8
from DRS 13 pages Form of Series H Preferred Purchase Warrant Oragenics, Inc
12/34/56
EX-4.3
from 8-K 1 page Second Amendment to Oragenics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-4.3
from S-8 1 page Second Amendment to Oragenics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-4.3
from 8-K 14 pages Oragenics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of September 4, 2024 Warrant Agency Agreement
12/34/56
EX-4.2
from 8-K 18 pages Form of Representative’s Common Stock Purchase Warrant Oragenics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Warrant to Purchase Shares of Common Stock Oragenics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Form of Representative’s Common Stock Purchase Warrant Oragenics, Inc
12/34/56
EX-4.8
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 8 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 15 pages Form of Representative’s Warrant Agreement Warrant to Purchase Common Stock Oragenics, Inc
12/34/56
EX-4.2
from 8-K 1 page Amendment to Oragenics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-4.1
from 8-K 22 pages 2021 Equity Incentive Plan Oragenics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-4.9
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56